Koru Medical presents KORU FreedomEdge Infusion System data

KORU Medical (KRMD) this week presented data demonstrating nursing preference for the use of the KORU FreedomEdge(R) Infusion System to administer subcutaneous oncology infusions in the clinic setting. The results of the case study were presented at the PODD 2024 Conference on October 28, 2024, in Boston, Massachusetts. The objective of the Nursing Preference Study was to assess time spent with patients, impact on nursing and patient comfort, and overall nurse preference when comparing manual syringe administration versus mechanical pump administration with the KORU FreedomEdge(R) Infusion System during subcutaneous oncology biologic drug infusions. The study was conducted by KORU Medical across 6 hospitals in Denmark with 33 nurses administering more than 3,000 infusions of a greater than10mL oncology drug with an average administration time of approximately 10 minutes. 97% of nurses reported having more time to interact with patients while using the KORU FreedomEdge(R) Infusion System versus manual syringe administration. 81% of nurses experienced less hand pain while using the KORU FreedomEdge(R) Infusion System compared to manual syringe administration. 73% of nurses observed less patient pain during infusions with the KORU FreedomEdge(R) Infusion System versus manual syringe administration.